Technology area: Chemistry & Materials
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Xona Microfluidics Inc. maintains 1 pending office action in the Chemistry & Materials technology area. A single distinct examiner, MICHAEL STANLEY GZYBOWSKI, is responsible for this 1 pending office action. Prosecution occurs within 1 distinct art unit. This distribution shows that the company's current active prosecution is concentrated under one examiner.
The 1 pending office action represents the total volume of current interaction with the patent office. Since the prosecution is situated within the Chemistry & Materials technology area, the company's legal focus remains specialized. MICHAEL STANLEY GZYBOWSKI, as the busiest examiner with 1 pending office action, is the sole point of contact for the company's active intellectual property matters. This 1 distinct examiner and 1 distinct art unit arrangement simplifies the management of the current portfolio, as there are no competing deadlines or varying examiner styles to navigate.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GZYBOWSKI, MICHAEL STANLEY | 1 | 67.8% | +52.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18226690 | APPARATUS AND METHOD FOR GROWING NEURAL CELLS AND COMPARTMENTALIZING AXONS AND DENDRITES | GZYBOWSKI, MICHAEL STANLEY | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18226690 | APPARATUS AND METHOD FOR GROWING NEURAL CELLS AND COMPARTMENTALIZING AXONS AND DENDRITES | GZYBOWSKI, MICHAEL STANLEY | — |
| Art Unit | Apps |
|---|---|
| 1798 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18226690 | APPARATUS AND METHOD FOR GROWING NEURAL CELLS AND COMPARTMENTALIZING AXONS AND DENDRITES | GZYBOWSKI, MICHAEL STANLEY | 1798 | §103§112 | Non-Final OA | — | Pending | Jul 26, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialXona Microfluidics Inc. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Michael Stanley Gzybowski has the most, with 1 of Xona Microfluidics Inc.'s pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.